Veterinary medicines European public assessment report (EPAR): Equidormin, midazolam, Status: Application withdrawn

Equidormin RSS Application withdrawn The application for this medicine has been withdrawn midazolam Medicine Veterinary Application withdrawn Application under evaluation Withdrawal of application Key facts Name of medicine Equidormin Active substance midazolam International non-proprietary name (INN) or common name midazolam Species Horses EMA product number EMEA/V/C/006593 Marketing authorisation applicant CP-Pharma Handelsgesellschaft mbH Withdrawal of application 09/09/2025 All documents Withdrawal letter : Equidormin English (EN) (329.6 KB - PDF) First published: 10/04/2026 View Withdrawal assessment report for Equidormin Adopted Reference Number: EMA/301662/2025 English (EN) (374.31 KB - PDF) First published: 10/04/2026 View Related information on withdrawals The question-and-answer (Q&A) document provides a summary of the CVMP's evaluation of the medicine at the time of the withdrawal of the application, and includes a link to the company's formal withdrawal letter. An assessment report is published when the application is withdrawn after the first stage of the CVMP's evaluation is completed ('day 120'). This page was last updated on 10/04/2026 Share this page